Dr. Wendy Huang Joined AnnJi as President and CEO in March 2019. Dr. Huang worked in multinational pharmaceutical companies for more than 30 years and held several leadership and executive positions. She brought extensive experience in drug development, registration, licensing and organization development.
In August 2019 AnnJi received new investments from Taiwan’s major venture capitals, including Taiwania Capital (lead), Fubon Financial Holding Venture Capital, SinoPac Venture Capital, and Eminent Venture Capital.
We look forward to further discussions with you.
Please fill out the form, and we will get right back to you.